General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
This report aims to provide a comprehensive presentation of the global market for General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthesia Drugs. This report contains market size and forecasts of General Anesthesia Drugs in global, including the following market information:
Global General Anesthesia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global General Anesthesia Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five General Anesthesia Drugs companies in 2022 (%)
The global General Anesthesia Drugs market was valued at US$ 7742.8 million in 2022 and is projected to reach US$ 9256.7 million by 2029, at a CAGR of 2.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the General Anesthesia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global General Anesthesia Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global General Anesthesia Drugs Market Segment Percentages, by Type, 2022 (%)
- Propofol
- Etomidate
- Midazolam
- Sevoflurane
- Isoflurane
- Others
Global General Anesthesia Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global General Anesthesia Drugs Market Segment Percentages, by Application, 2022 (%)
- Intravenous Anesthetics
- Inhalational Anesthetics
Global General Anesthesia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global General Anesthesia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies General Anesthesia Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies General Anesthesia Drugs revenues share in global market, 2022 (%)
Key companies General Anesthesia Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies General Anesthesia Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Astrazeneca
- Fresenius-Kabi
- AbbVie
- Baxter Healthcare
- B.Braun
- Maruishi
- Piramal
- Hikma Pharmaceuticals
- Mylan
- Nhwa
- Hengrui
- Lunan
Outline of Major Chapters:
Chapter 1: Introduces the definition of General Anesthesia Drugs, market overview.
Chapter 2: Global General Anesthesia Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global General Anesthesia Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
General Anesthesia Drugs Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 General Anesthesia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global General Anesthesia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global General Anesthesia Drugs Overall Market Size
2.1 Global General Anesthesia Drugs Market Size: 2022 VS 2029
2.2 Global General Anesthesia Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global General Anesthesia Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top General Anesthesia Drugs Players in Global Market
3.2 Top Global General Anesthesia Drugs Companies Ranked by Revenue
3.3 Global General Anesthesia Drugs Revenue by Companies
3.4 Global General Anesthesia Drugs Sales by Companies
3.5 Global General Anesthesia Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 General Anesthesia Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers General Anesthesia Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 General Anesthesia Drugs Players in Global Market
3.8.1 List of Global Tier 1 General Anesthesia Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 General Anesthesia Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global General Anesthesia Drugs Market Size Markets, 2022 & 2029
4.1.2 Propofol
4.1.3 Etomidate
4.1.4 Midazolam
4.1.5 Sevoflurane
4.1.6 Isoflurane
4.1.7 Others
4.2 By Type - Global General Anesthesia Drugs Revenue & Forecasts
4.2.1 By Type - Global General Anesthesia Drugs Revenue, 2018-2023
4.2.2 By Type - Global General Anesthesia Drugs Revenue, 2024-2029
4.2.3 By Type - Global General Anesthesia Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global General Anesthesia Drugs Sales & Forecasts
4.3.1 By Type - Global General Anesthesia Drugs Sales, 2018-2023
4.3.2 By Type - Global General Anesthesia Drugs Sales, 2024-2029
4.3.3 By Type - Global General Anesthesia Drugs Sales Market Share, 2018-2029
4.4 By Type - Global General Anesthesia Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global General Anesthesia Drugs Market Size, 2022 & 2029
5.1.2 Intravenous Anesthetics
5.1.3 Inhalational Anesthetics
5.2 By Application - Global General Anesthesia Drugs Revenue & Forecasts
5.2.1 By Application - Global General Anesthesia Drugs Revenue, 2018-2023
5.2.2 By Application - Global General Anesthesia Drugs Revenue, 2024-2029
5.2.3 By Application - Global General Anesthesia Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global General Anesthesia Drugs Sales & Forecasts
5.3.1 By Application - Global General Anesthesia Drugs Sales, 2018-2023
5.3.2 By Application - Global General Anesthesia Drugs Sales, 2024-2029
5.3.3 By Application - Global General Anesthesia Drugs Sales Market Share, 2018-2029
5.4 By Application - Global General Anesthesia Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global General Anesthesia Drugs Market Size, 2022 & 2029
6.2 By Region - Global General Anesthesia Drugs Revenue & Forecasts
6.2.1 By Region - Global General Anesthesia Drugs Revenue, 2018-2023
6.2.2 By Region - Global General Anesthesia Drugs Revenue, 2024-2029
6.2.3 By Region - Global General Anesthesia Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global General Anesthesia Drugs Sales & Forecasts
6.3.1 By Region - Global General Anesthesia Drugs Sales, 2018-2023
6.3.2 By Region - Global General Anesthesia Drugs Sales, 2024-2029
6.3.3 By Region - Global General Anesthesia Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America General Anesthesia Drugs Revenue, 2018-2029
6.4.2 By Country - North America General Anesthesia Drugs Sales, 2018-2029
6.4.3 US General Anesthesia Drugs Market Size, 2018-2029
6.4.4 Canada General Anesthesia Drugs Market Size, 2018-2029
6.4.5 Mexico General Anesthesia Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe General Anesthesia Drugs Revenue, 2018-2029
6.5.2 By Country - Europe General Anesthesia Drugs Sales, 2018-2029
6.5.3 Germany General Anesthesia Drugs Market Size, 2018-2029
6.5.4 France General Anesthesia Drugs Market Size, 2018-2029
6.5.5 U.K. General Anesthesia Drugs Market Size, 2018-2029
6.5.6 Italy General Anesthesia Drugs Market Size, 2018-2029
6.5.7 Russia General Anesthesia Drugs Market Size, 2018-2029
6.5.8 Nordic Countries General Anesthesia Drugs Market Size, 2018-2029
6.5.9 Benelux General Anesthesia Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia General Anesthesia Drugs Revenue, 2018-2029
6.6.2 By Region - Asia General Anesthesia Drugs Sales, 2018-2029
6.6.3 China General Anesthesia Drugs Market Size, 2018-2029
6.6.4 Japan General Anesthesia Drugs Market Size, 2018-2029
6.6.5 South Korea General Anesthesia Drugs Market Size, 2018-2029
6.6.6 Southeast Asia General Anesthesia Drugs Market Size, 2018-2029
6.6.7 India General Anesthesia Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America General Anesthesia Drugs Revenue, 2018-2029
6.7.2 By Country - South America General Anesthesia Drugs Sales, 2018-2029
6.7.3 Brazil General Anesthesia Drugs Market Size, 2018-2029
6.7.4 Argentina General Anesthesia Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa General Anesthesia Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa General Anesthesia Drugs Sales, 2018-2029
6.8.3 Turkey General Anesthesia Drugs Market Size, 2018-2029
6.8.4 Israel General Anesthesia Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia General Anesthesia Drugs Market Size, 2018-2029
6.8.6 UAE General Anesthesia Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Company Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca General Anesthesia Drugs Major Product Offerings
7.1.4 Astrazeneca General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Astrazeneca Key News & Latest Developments
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Company Summary
7.2.2 Fresenius-Kabi Business Overview
7.2.3 Fresenius-Kabi General Anesthesia Drugs Major Product Offerings
7.2.4 Fresenius-Kabi General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Fresenius-Kabi Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie General Anesthesia Drugs Major Product Offerings
7.3.4 AbbVie General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Company Summary
7.4.2 Baxter Healthcare Business Overview
7.4.3 Baxter Healthcare General Anesthesia Drugs Major Product Offerings
7.4.4 Baxter Healthcare General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Baxter Healthcare Key News & Latest Developments
7.5 B.Braun
7.5.1 B.Braun Company Summary
7.5.2 B.Braun Business Overview
7.5.3 B.Braun General Anesthesia Drugs Major Product Offerings
7.5.4 B.Braun General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.5.5 B.Braun Key News & Latest Developments
7.6 Maruishi
7.6.1 Maruishi Company Summary
7.6.2 Maruishi Business Overview
7.6.3 Maruishi General Anesthesia Drugs Major Product Offerings
7.6.4 Maruishi General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Maruishi Key News & Latest Developments
7.7 Piramal
7.7.1 Piramal Company Summary
7.7.2 Piramal Business Overview
7.7.3 Piramal General Anesthesia Drugs Major Product Offerings
7.7.4 Piramal General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Piramal Key News & Latest Developments
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Company Summary
7.8.2 Hikma Pharmaceuticals Business Overview
7.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Major Product Offerings
7.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Hikma Pharmaceuticals Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan General Anesthesia Drugs Major Product Offerings
7.9.4 Mylan General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Nhwa
7.10.1 Nhwa Company Summary
7.10.2 Nhwa Business Overview
7.10.3 Nhwa General Anesthesia Drugs Major Product Offerings
7.10.4 Nhwa General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Nhwa Key News & Latest Developments
7.11 Hengrui
7.11.1 Hengrui Company Summary
7.11.2 Hengrui General Anesthesia Drugs Business Overview
7.11.3 Hengrui General Anesthesia Drugs Major Product Offerings
7.11.4 Hengrui General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Hengrui Key News & Latest Developments
7.12 Lunan
7.12.1 Lunan Company Summary
7.12.2 Lunan General Anesthesia Drugs Business Overview
7.12.3 Lunan General Anesthesia Drugs Major Product Offerings
7.12.4 Lunan General Anesthesia Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Lunan Key News & Latest Developments
8 Global General Anesthesia Drugs Production Capacity, Analysis
8.1 Global General Anesthesia Drugs Production Capacity, 2018-2029
8.2 General Anesthesia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global General Anesthesia Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 General Anesthesia Drugs Supply Chain Analysis
10.1 General Anesthesia Drugs Industry Value Chain
10.2 General Anesthesia Drugs Upstream Market
10.3 General Anesthesia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 General Anesthesia Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of General Anesthesia Drugs in Global Market
Table 2. Top General Anesthesia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global General Anesthesia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global General Anesthesia Drugs Revenue Share by Companies, 2018-2023
Table 5. Global General Anesthesia Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global General Anesthesia Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers General Anesthesia Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers General Anesthesia Drugs Product Type
Table 9. List of Global Tier 1 General Anesthesia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 General Anesthesia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global General Anesthesia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global General Anesthesia Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global General Anesthesia Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global General Anesthesia Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global General Anesthesia Drugs Sales (K Units), 2024-2029
Table 16. By Application - Global General Anesthesia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global General Anesthesia Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global General Anesthesia Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global General Anesthesia Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global General Anesthesia Drugs Sales (K Units), 2024-2029
Table 21. By Region - Global General Anesthesia Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global General Anesthesia Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global General Anesthesia Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global General Anesthesia Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global General Anesthesia Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America General Anesthesia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America General Anesthesia Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America General Anesthesia Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America General Anesthesia Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe General Anesthesia Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe General Anesthesia Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe General Anesthesia Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe General Anesthesia Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia General Anesthesia Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia General Anesthesia Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia General Anesthesia Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia General Anesthesia Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America General Anesthesia Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America General Anesthesia Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America General Anesthesia Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America General Anesthesia Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa General Anesthesia Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa General Anesthesia Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa General Anesthesia Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa General Anesthesia Drugs Sales, (K Units), 2024-2029
Table 46. Astrazeneca Company Summary
Table 47. Astrazeneca General Anesthesia Drugs Product Offerings
Table 48. Astrazeneca General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Astrazeneca Key News & Latest Developments
Table 50. Fresenius-Kabi Company Summary
Table 51. Fresenius-Kabi General Anesthesia Drugs Product Offerings
Table 52. Fresenius-Kabi General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Fresenius-Kabi Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie General Anesthesia Drugs Product Offerings
Table 56. AbbVie General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Baxter Healthcare Company Summary
Table 59. Baxter Healthcare General Anesthesia Drugs Product Offerings
Table 60. Baxter Healthcare General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Baxter Healthcare Key News & Latest Developments
Table 62. B.Braun Company Summary
Table 63. B.Braun General Anesthesia Drugs Product Offerings
Table 64. B.Braun General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. B.Braun Key News & Latest Developments
Table 66. Maruishi Company Summary
Table 67. Maruishi General Anesthesia Drugs Product Offerings
Table 68. Maruishi General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Maruishi Key News & Latest Developments
Table 70. Piramal Company Summary
Table 71. Piramal General Anesthesia Drugs Product Offerings
Table 72. Piramal General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Piramal Key News & Latest Developments
Table 74. Hikma Pharmaceuticals Company Summary
Table 75. Hikma Pharmaceuticals General Anesthesia Drugs Product Offerings
Table 76. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Hikma Pharmaceuticals Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan General Anesthesia Drugs Product Offerings
Table 80. Mylan General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Nhwa Company Summary
Table 83. Nhwa General Anesthesia Drugs Product Offerings
Table 84. Nhwa General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Nhwa Key News & Latest Developments
Table 86. Hengrui Company Summary
Table 87. Hengrui General Anesthesia Drugs Product Offerings
Table 88. Hengrui General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Hengrui Key News & Latest Developments
Table 90. Lunan Company Summary
Table 91. Lunan General Anesthesia Drugs Product Offerings
Table 92. Lunan General Anesthesia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Lunan Key News & Latest Developments
Table 94. General Anesthesia Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global General Anesthesia Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global General Anesthesia Drugs Production by Region, 2018-2023 (K Units)
Table 97. Global General Anesthesia Drugs Production by Region, 2024-2029 (K Units)
Table 98. General Anesthesia Drugs Market Opportunities & Trends in Global Market
Table 99. General Anesthesia Drugs Market Drivers in Global Market
Table 100. General Anesthesia Drugs Market Restraints in Global Market
Table 101. General Anesthesia Drugs Raw Materials
Table 102. General Anesthesia Drugs Raw Materials Suppliers in Global Market
Table 103. Typical General Anesthesia Drugs Downstream
Table 104. General Anesthesia Drugs Downstream Clients in Global Market
Table 105. General Anesthesia Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. General Anesthesia Drugs Segment by Type in 2022
Figure 2. General Anesthesia Drugs Segment by Application in 2022
Figure 3. Global General Anesthesia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global General Anesthesia Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global General Anesthesia Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. General Anesthesia Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by General Anesthesia Drugs Revenue in 2022
Figure 9. By Type - Global General Anesthesia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global General Anesthesia Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global General Anesthesia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global General Anesthesia Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global General Anesthesia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global General Anesthesia Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 23. US General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 28. Germany General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 37. China General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 44. Brazil General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa General Anesthesia Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa General Anesthesia Drugs Sales Market Share, 2018-2029
Figure 48. Turkey General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE General Anesthesia Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global General Anesthesia Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production General Anesthesia Drugs by Region, 2022 VS 2029
Figure 54. General Anesthesia Drugs Industry Value Chain
Figure 55. Marketing Channels
Global Sevoflurane Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Sevoflurane market size was valued at US$ 1293.8 million in 2023. With growing demand in downstream market, the Sevoflurane is forecast to a readjusted size of US$ 1247.6 million by 2030 with a CAGR of -0.5% during review period.
The research report highlights the growth potential of the global Sevoflurane market. Sevoflurane are expected to show stable growth in the future market. However, product differentiation, reducing c......
Global Remifentanil Hydrochloride Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Remifentanil Hydrochloride market size was valued at US$ million in 2023. With growing demand in downstream market, the Remifentanil Hydrochloride is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Remifentanil Hydrochloride market. Remifentanil Hydrochloride are expected to show stable growth in the future market. How......
Global General Anesthesia Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 111
According to our LPI (LP Information) latest study, the global General Anesthesia Drugs market size was valued at US$ 3840.3 million in 2023. With growing demand in downstream market, the General Anesthesia Drugs is forecast to a readjusted size of US$ 4929.3 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global General Anesthesia Drugs market. General Anesthesia Drugs are expected to show stable growth in the future m......
Global Sevoflurane Source Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Sevoflurane Source market size was valued at US$ 1192.7 million in 2023. With growing demand in downstream market, the Sevoflurane Source is forecast to a readjusted size of US$ 1509.6 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Sevoflurane Source market. Sevoflurane Source are expected to show stable growth in the future market. However, product ......
Global Anesthesia Drugs Market Research Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 2680 Onwards Pages: 166
Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
Global Anesthesia Drugs Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 108
Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
Global Sevoflurane Professional Survey Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 3280 Onwards Pages: 109
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
Global Sevoflurane Market Research Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 2680 Onwards Pages: 132
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
Global Sevoflurane Source Market Research Report 2023, Forecast to 2028
Published: 14-Nov-2023 Price: US 2680 Onwards Pages: 137
Sevoflurane Source is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerg......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
